(Q40588228)

21 September 2017

title

Generation and characterization of P gene-deficient rabies virus (English)

1 reference

21 September 2017

0 references

rabies virus

1 reference

4

Ichiro Kurane

1 reference

21 September 2017

Youko Shoji

1

1 reference

21 September 2017

Satoshi Inoue

2

1 reference

21 September 2017

Kazuo Nakamichi

3

1 reference

21 September 2017

Takeo Sakai

5

1 reference

21 September 2017

Kinjiro Morimoto

6

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2004

1 reference

21 September 2017

1 reference

21 September 2017

volume

318

1 reference

21 September 2017

issue

1

1 reference

21 September 2017

page(s)

295-305

1 reference

NIH test, a problematic method for testing potency of inactivated rabies vaccine

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Gene expression of vesicular stomatitis virus genome RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

More antibody with less antigen: can immunogenicity of attenuated live virus vaccines be improved?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Nonsegmented negative-strand RNA viruses: genetics and manipulation of viral genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Overexpression of the rabies virus glycoprotein results in enhancement of apoptosis and antiviral immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Moving the glycoprotein gene of vesicular stomatitis virus to promoter-proximal positions accelerates and enhances the protective immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Rearrangement of the genes of vesicular stomatitis virus eliminates clinical disease in the natural host: new strategy for vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Both the N- and the C-terminal domains of the nominal phosphoprotein of rabies virus are involved in binding to the nucleoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Robust recall and long-term memory T-cell responses induced by prime-boost regimens with heterologous live viral vectors expressing human immunodeficiency virus type 1 Gag and Env proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

An improved method for recovering rabies virus from cloned cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Cross-reactive antigenicity of nucleoproteins of lyssaviruses recognized by a monospecific antirabies virus nucleoprotein antiserum on paraffin sections of formalin-fixed tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Cytoplasmic dynein LC8 interacts with lyssavirus phosphoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Functional interaction map of lyssavirus phosphoprotein: identification of the minimal transcription domains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Second-generation rabies virus-based vaccine vectors expressing human immunodeficiency virus type 1 gag have greatly reduced pathogenicity but are highly immunogenic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Extensive attenuation of rabies virus by simultaneously modifying the dynein light chain binding site in the P protein and replacing Arg333 in the G protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Budding of rabies virus particles in the absence of the spike glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Genetic engineering of live rabies vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

A decade after the generation of a negative-sense RNA virus from cloned cDNA - what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Cytokines and costimulatory molecules as genetic adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Interaction of the rabies virus P protein with the LC8 dynein light chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Polymerase activity of in vitro mutated rabies virus L protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Infectious rabies viruses from cloned cDNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Vaccines against intracellular infections requiring cellular immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Studies on the rabies virus RNA polymerase: 2. Possible relationships between the two forms of the non-catalytic subunit (P protein).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Influenza A virus with defective M2 ion channel activity as a live vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Immunogenicity and protective efficacy of replication-incompetent influenza virus-like particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Mapping the interacting domains between the rabies virus polymerase and phosphoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Matrix protein of rabies virus is responsible for the assembly and budding of bullet-shaped particles and interacts with the transmembrane spike glycoprotein G.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2003.10.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2003.10.001

1 reference

21 September 2017

1 reference